Recent changes
Jump to navigation
Jump to search
Track the most recent changes to the wiki on this page.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
23 May 2024
|
|
N 14:51 | Glofitamab-gxbm 2 changes history +8,803 [Muhammad Waleed (2×)] | |||
|
|
14:51 (cur | prev) +6,189 Muhammad Waleed talk contribs | ||||
| N |
|
14:40 (cur | prev) +2,614 Muhammad Waleed talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Muhammad Waleed, M.B.B.S. [mailto:muhammad_waleed@ymail.com] |genericName=glofitamab. |aOrAn=a |drugClass=bispecific antibodies |indicationType=treatment |indication=COLUMVI (glofitamab) has been approved by the FDA for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS), or large B-cell lymphoma arising from follicular lymphoma aft...") | |||
|
|
N 14:22 | Rozanolixizumab-noli 2 changes history +8,759 [Muhammad Waleed (2×)] | |||
|
|
14:22 (cur | prev) +5,524 Muhammad Waleed talk contribs | ||||
| N |
|
12:43 (cur | prev) +3,235 Muhammad Waleed talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Muhammad Waleed, M.B.B.S. [mailto:muhammad_waleed@ymail.com] |genericName=Rozanolixizumab-noli (Rystiggo) |aOrAn=a |drugClass=Neonatal Fc receptor blocker |indicationType=treatment |indication=Rystiggo is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive. |adverseReac...") | |||
|
|
m 07:03 | Non-degenerate nucleotides per response element 2 changes history −98 [Marshallsumter (2×)] | |||
| m |
|
07:03 (cur | prev) −49 Marshallsumter talk contribs (→Tabulation of counts) | |||
| m |
|
07:01 (cur | prev) −49 Marshallsumter talk contribs (→Tabulation of counts) | |||
|
|
04:38 | Pegunigalsidase alfa-iwxj 4 changes history +3,608 [Alen Antony (4×)] | |||
|
|
04:38 (cur | prev) +1,255 Alen Antony talk contribs | ||||
|
|
02:34 (cur | prev) +83 Alen Antony talk contribs | ||||
|
|
02:32 (cur | prev) +931 Alen Antony talk contribs | ||||
|
|
02:18 (cur | prev) +1,339 Alen Antony talk contribs | ||||
|
|
02:01 | Template:KDRG 2 changes history +15 [Kosar Doraghi (2×)] | |||
|
|
02:01 (cur | prev) +18 Kosar Doraghi talk contribs | ||||
|
|
02:00 (cur | prev) −3 Kosar Doraghi talk contribs | ||||
| N 02:00 | Aprocitentan diffhist +16,419 Kosar Doraghi talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar.Doraghi, M.D.[mailto:k.doraghi@yahoo.com] |genericName=aprocitentan |aOrAn=an |drugClass=endothelin receptor antagonist |indicationType=treatment |indication=hypertension in combination with other antihypertensive drugs, to lower blood pressure in adult patients who are not adequately controlled on other drugs |hasBlackBoxWarning=Yes |adverseReactions=edema/fluid retention and anemia |blackBoxWarningTitle=W...") | ||||
|
|
01:49 | (Upload log) [Kosar Doraghi (3×)] | |||
|
|
01:49 Kosar Doraghi talk contribs uploaded File:IMG 1225.jpeg | ||||
|
|
01:28 Kosar Doraghi talk contribs uploaded File:IMG 1224.jpeg | ||||
|
|
01:28 Kosar Doraghi talk contribs uploaded File:IMG 1223.jpeg | ||||
| 00:06 | Sandbox diffhist +9 Alberto Castro Molina talk contribs | ||||
22 May 2024
| 23:54 | Sandbox diffhist −30,274 Alberto Castro Molina talk contribs (Replaced content with " File:Captura de Pantalla 2024-05-18 a la(s) 9.33.11 p.m..png") | ||||
_9.33.11_p.m..png){kind=link}
| 23:53 | Upload log Alberto Castro Molina talk contribs uploaded File:Captura de Pantalla 2024-05-18 a la(s) 9.33.11 p.m..png | ||||
| m 21:33 | Non-degenerate nucleotides per response element diffhist 0 Marshallsumter talk contribs (→Tabulation of counts) | ||||